Market research
6849.TSE Nihon Kohden Corporation
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 246B
- P/E ratio
- 17.26
- Analyst target
- 1800
- Dividend yield
- 2.1%
- Beta
- 0.37
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- JP3706800004
- Market cap
- 246B
- P/E ratio
- 17.26
- Analyst target
- 1800
- Dividend yield
- 2.1%
- Beta
- 0.37
About
About Nihon Kohden Corporation
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors, including central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers defibrillators, automated external defibrillators(AED), ventilators, pacemakers, anesthesia machines, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 6849.TSE discussion.
5 years, 5 months ago
Nihon Kohden Corporation is currently in a long term uptrend where the price is trading 0.6% above its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Nihon Kohden Corporation's total revenue rose by 25.2% to $50B since the same quarter in the previous year.
Its net income has increased by 243.8% to $3B since the same quarter in the previous year.
Finally, its free cash flow fell by 80.0% to $172M since the same quarter in the previous year.
Based on the above factors, Nihon Kohden Corporation gets an overall score of 4/5.